Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 54,093	$ 37,187
Short-term investments	118,371	102,614
Accounts receivable, net	73,881	68,828
Inventory	46,762	40,410
Licensing receivable	0	90,000
Prepaid expenses and other current assets	9,706	16,611
Total current assets	302,813	355,650
Property, plant, and equipment, net	50,296	51,472
Operating lease right-of-use assets	20,760	22,669
Other assets	1,721	1,600
Total assets	375,590	431,391
Current liabilities
Accounts payable	9,062	8,285
Accrued expenses and other current liabilities	119,398	112,341
Operating lease liabilities	4,873	4,365
Total current liabilities	133,333	124,991
Convertible notes, net	312,588	234,527
Deferred revenue, non-current	70,881	64,315
Operating lease liabilities, non-current	19,525	21,751
Other non-current liabilities	3,245	3,140
Total liabilities	539,572	448,724
Commitments and contingencies (Note 12)
Stockholders’ deficit
Preferred stock, $0.001 par value; 15,000,000 shares authorized as of September 30, 2022 and December 31, 2021; none issued and outstanding	0	0
Common stock, $0.001 par value; 150,000,000 shares authorized as of September 30, 2022 and December 31, 2021; 49,390,503 and 48,444,473 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	49	48
Additional paid-in capital	1,024,809	1,136,656
Accumulated other comprehensive loss	(803)	(126)
Accumulated deficit	(1,188,037)	(1,153,911)
Total stockholders’ deficit	(163,982)	(17,333)
Total liabilities and stockholders’ deficit	$ 375,590	$ 431,391